Antiplatelet archivos | Page 25 of 26

Acute coronary syndromes

Decreased bleeding with radial access leaves little to bivalirudin for additional benefit

Original title: Bivalirudin or heparin in primary angioplasty performed through the transradial approach: results from a multicentre registry. Reference: Sciahbasi...

solaci - 31 January, 2014

Learn More

Acute coronary syndromes

Bivalirudin, effective in the pre-hospitalization phase of infarction

Original title: Bivalirudin Started during Emergency Transport for Primary PCI. Reference: Philippe G. Steg, et;al. NEJM 2013; Octubre 30:1-11Primary PCI...

solaci - 5 November, 2013

Learn More

Acute coronary syndromes

Low cardiac mortality with bivalirudin beyond the reduction in major bleeding

Original title: Reduction in Cardiac Mortality with Bivalirudin in Patients With and Without Major Bleeding: The HORIZONS-AMI Trial. Reference: Gregg...

solaci - 21 October, 2013

Learn More

Antiplatelet

Enoxaparin appears superior to unfractionated heparin in patients undergoing primary angioplasty

Original title: A direct comparison of intravenous enoxaparin with unfractionated heparin in primary percutaneous coronary intervention (from the...

solaci - 16 September, 2013

Learn More

Antiplatelet

Rivaroxaban reduces in-stent thrombosis in patients with acute coronary syndromes

Original title: Reduction of Stent Thrombosis in Patients With Acute Coronary Syndromes Treated With Rivaroxaban in ATLAS-ACS 2...

solaci - 23 August, 2013

Learn More

Antiplatelet

Transradial access plus bivalirudin, the best combination to reduce bleeding

Original title: Comparison of bivalirudin and radial access across a spectrum of preprocedural risk of bleeding in percutaneous...

solaci - 15 August, 2013

Learn More

Antiplatelet

Rational use of bivalirudin, less bleeding and less costs using risk score

Original title: Pre-Procedural Estimate of Individualized Bleeding Risk Impacts Physicians’ Utilization of Bivalirudin During Percutaneous Coronary Intervention. Reference: Seshu C....

solaci - 2 July, 2013

Learn More

Acute coronary syndromes

Improved efficacy and also increased bleeding with Rivaroxaban in Acute Myocardial Infarction

Original title: Rivaroxaban in Patients Stabilized After a ST-Segment Elevation Myocardial Infarction. Results From the ATLAS ACS-2–TIMI-51 Trial....

solaci - 7 May, 2013

Learn More

Antiplatelet

Decreased bleeding with radial access leaves little to bivalirudin for additional benefit

Bivalirudin, effective in the pre-hospitalization phase of infarction

Low cardiac mortality with bivalirudin beyond the reduction in major bleeding

Enoxaparin appears superior to unfractionated heparin in patients undergoing primary angioplasty

Rivaroxaban reduces in-stent thrombosis in patients with acute coronary syndromes

Transradial access plus bivalirudin, the best combination to reduce bleeding

Rational use of bivalirudin, less bleeding and less costs using risk score

Improved efficacy and also increased bleeding with Rivaroxaban in Acute Myocardial Infarction

Last News

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Institutional News

Check out the best images of the El Salvador 2024 Sessions

The El Salvador 2024 Sessions are coming soon

Check out the best images of the Arequipa 2024 Sessions

Access